Contents

Current Medicinal Chemistry, Volume 20 - Number 30

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy

, 20(30): 3677 - 3692

Y. Yang, S. Karakhanova, J. Werner and A. V. Bazhin


DOI: 10.2174/0929867311320999165




Heterocyclic HIV-Protease Inhibitors

, 20(30): 3693 - 3710

C. Calugi, A. Guarna and A. Trabocchi


DOI: 10.2174/09298673113209990135




A Focus on Heme Oxygenase-1 (HO-1) Inhibitors

, 20(30): 3711 - 3732

V. Pittalà, L. Salerno, G. Romeo, M. N. Modica and M. A. Siracusa


DOI: 10.2174/0929867311320300003




A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir

, 20(30): 3733 - 3742

I. Gentile, F. Borgia, A. R. Buonomo, G. Castaldo and G. Borgia


DOI: 10.2174/09298673113209990178




Sulfur-based Mechanistic Probes for Enzyme-catalyzed Reactions

, 20(30): 3743 - 3758

Weiping Zheng


DOI: 10.2174/09298673113209990177




The Renaissance of Polymyxins

, 20(30): 3759 - 3773

B. Kadar, B. Kocsis, K. Nagy and D. Szabo


DOI: 10.2174/09298673113209990185




Gene Therapy, A Targeted Treatment for Diabetic Nephropathy

, 20(30): 3774 - 3784

X. Lin, L. Tao and D. Tang


DOI: 10.2174/09298673113209990183




Tuberculosis Clinical Trial Update and the Current Anti-Tuberculosis Drug Portfolio

, 20(30): 3785 - 3796

Juan Carlos Palomino and Anandi Martin


DOI: 10.2174/09298673113209990166




Carbasugar Probes to Explore the Enzyme Binding Pocket at the Anomeric Position: Application to the Design of Golgi Mannosidase II Inhibitors

, 20(30): 3797 - 3801

M. V. Vinader and K. Afarinkia


DOI: 10.2174/09298673113209990180




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science